Alison Turner

Alison Turner is a professional with a strong background in managing viral vector seed stocks for GMP manufacturing and developing USP and DSP technologies to enhance vaccine product efficiency and quality.

She holds a BSc in Biology with First Class Honours from the University of Southampton and a D.Phil. focused on protein interactions within the immune system from the University of Oxford.

Alison has held key roles such as Director of Process Development at Vaccitech Limited, VVCF Manager at the University of Oxford, Senior Scientist in Cell Biology at Medigene Limited, Post-doctoral Research Scientist at Klenerman Group (Oxford University), and Senior Analytical Scientist at OXXON THERAPEUTICS LIMITED.